GEN Roundup on Cell-Line Authentication

GEN Roundup on Cell-Line Authentication
Baxter, CTI Ink $ 172M+ Licensing Deal for Myelofibrosis Drug … They also noted that even though techniques and culture conditions have improved, the problem of misidentified cell lines or cellular cross-contamination remains at a very high level …
Read more on Genetic Engineering News

Titan Pharmaceuticals, Inc. (TTNP): Titan Pharmaceuticals' CEO Discusses Q3
In light of the delay and the changing commercial landscape Braeburn approached Titan and explained their need to modify the terms of our agreement in order to enable them to move forward with the program. In turn, the delays have … Given the …
Read more on Seeking Alpha

Where do you recommend registration for diagnostic assessment tools? — For on-line self service Diagnostic Assessment Tools, it is recommended that you let the user answer the questions and see a high level summary of results fi…